KELLY WHATLEY: Open Payments
NPI 1396429171 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 35 payments from 14 companies in 2025. Trend: 2023 $190 · 2024 $875 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| Abbott Laboratories | 1 | $147 |
| Novo Nordisk Inc | 5 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $111 |
| SCPHARMACEUTICALS INC. | 3 | $94 |
| PFIZER INC. | 5 | $94 |
| AtriCure, Inc. | 1 | $42 |
| Inspire Medical Systems, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
Products named: LEQVIO, CARDIOMEMS, Wegovy, JARDIANCE, FUROSCIX, VYNDAQEL, ATRICLIP LAA EXCLUSION SYSTEM, INSPIRE.
Industry payments across PA — which companies pay providers there.
